# TNFAIP8L2

## Overview
TNFAIP8L2 is a gene that encodes the protein TNF alpha induced protein 8 like 2, commonly referred to as TIPE2. This protein is a member of the TIPE (TNF-alpha-induced protein 8-like) family, which is involved in the regulation of immune responses and inflammation. TIPE2 is a cytoplasmic protein characterized by a conserved TIPE homology (TH) domain, which plays a crucial role in its function as an immune checkpoint regulator. The protein is primarily expressed in lymphoid tissues and is involved in modulating key signaling pathways such as NF-κB and MAPK, which are essential for maintaining immune homeostasis and regulating autophagy (Sullivan2017Evolutionary; Bordoloi2018TIPE). Through its interactions with proteins like RAC1 and RIG-I, TIPE2 influences cellular processes related to immune response and tumorigenesis, making it a significant focus of research in cancer and inflammatory diseases (Zou2021Tumor; Li2020TNFAIP8L2TIPE2).

## Structure
The TNFAIP8L2 gene encodes the TIPE2 protein, which is part of the TIPE family involved in immune regulation and inflammation. TIPE2 is a cytoplasmic protein consisting of 184 amino acids and is primarily expressed in lymphoid tissues (Bordoloi2018TIPE). The protein has a unique molecular structure characterized by a conserved TIPE homology (TH) domain, which includes seven alpha helices (Sullivan2017Evolutionary). This domain forms a cylindrical structure with a central hydrophobic cavity, facilitating the binding of hydrophobic cofactors or substrates, likely phospholipids (Bordoloi2018TIPE).

The tertiary structure of TIPE2 is distinct, with a topology described as a mirror image of the death effector domain (DED), although it is larger, consisting of approximately 150 amino acids compared to the typical 90 amino acids found in DEDs (Bordoloi2018TIPE). The high-resolution crystal structure of TIPE2 reveals a unique fold, which is crucial for its function in regulating immune responses and tumorigenesis (Bordoloi2018TIPE). The protein's structure is integral to its role in modulating signaling pathways such as NF-κB and MAPK, contributing to its function as an immune checkpoint regulator (Bordoloi2018TIPE).

## Function
TNFAIP8L2, also known as TIPE2, is a protein that plays a significant role in regulating autophagy and immune responses in healthy human cells. It functions as a negative regulator of the MTORC1 pathway, which is crucial for cell growth and metabolism. TNFAIP8L2 inhibits MTORC1 activation by preventing the association between active RAC1 and MTOR on the lysosomal membrane, thereby modulating autophagy and cellular metabolism (Li2020TNFAIP8L2TIPE2). This regulation is essential for maintaining cellular homeostasis, particularly under conditions of nutrient starvation, where TNFAIP8L2 impairs autolysosome reformation and autophagy flux, potentially leading to cell death (Li2020TNFAIP8L2TIPE2).

In the immune system, TNFAIP8L2 is involved in maintaining immune homeostasis by negatively regulating inflammatory responses. It modulates the RAC1-MTORC1 axis, which is linked to the control of inflammation and immune responses (Li2020TNFAIP8L2TIPE2). TNFAIP8L2 also interacts with the RIG-I signaling pathway in macrophages, acting as a negative regulator of type I interferon responses, which are crucial for antiviral immunity (Zou2021Tumor). This interaction helps balance immune responses, preventing excessive inflammation while allowing for effective viral clearance (Zou2021Tumor).

## Clinical Significance
TNFAIP8L2, also known as TIPE2, plays a significant role in cancer progression and immune regulation. Alterations in its expression are linked to various cancers, including glioma, breast cancer, and lung adenocarcinoma. In glioma, high TNFAIP8L2 expression is associated with poor prognosis, including shorter overall survival and disease-specific survival (Zhang2024Comprehensive). Conversely, low expression of TNFAIP8L2 correlates with poor prognosis in breast cancer and lung adenocarcinoma (Chen2023Human).

The gene is also involved in immune cell infiltration and tumor microenvironment modulation. It affects the infiltration of immune cells such as CD8+ T cells and macrophages, influencing tumor progression and immune response (Chen2023Human). TNFAIP8L2's interaction with signaling pathways, including the Wnt/β-catenin and PI3K/AKT pathways, further implicates it in cancer progression and drug resistance (LIN2023Structure).

In addition to cancer, TNFAIP8L2 is involved in inflammatory responses. Its deficiency can exacerbate inflammation by upregulating MTOR activity, leading to increased pro-inflammatory cytokine levels (Li2020TNFAIP8L2TIPE2). These findings suggest that TNFAIP8L2 could serve as a biomarker and therapeutic target in cancer and inflammatory diseases.

## Interactions
TNFAIP8L2, also known as TIPE2, is involved in several protein interactions that influence cellular processes. It interacts with the GTP-binding protein RAC1, where it negatively regulates MTORC1 activity by preventing the association between active RAC1 and MTOR on the lysosomal membrane. This interaction is crucial for modulating MTOR signaling, as TNFAIP8L2 competes with MTOR for binding to the GTP-bound state of RAC1, thereby inhibiting MTORC1 activation and preventing RPS6 phosphorylation (Li2020TNFAIP8L2TIPE2).

TNFAIP8L2 also interacts with RIG-I, a key receptor in the antiviral response, through its caspase activation and recruitment domains (CARDs) and C-terminal domain (CTD). This interaction negatively regulates the RIG-I signaling pathway, inhibiting the production of type I interferons and other cytokines, thus modulating the immune response to RNA viruses (Zou2021Tumor).

In cancer, TNFAIP8L2 is involved in various signaling pathways, including the Ras-RalGDS/Ral-GEFs, Rac1, and PI3K/Akt pathways. It inhibits the expression of downstream genes involved in cell migration and invasion, such as MMP-9 and uPA, and modulates tumor progression by affecting the expression of β-catenin, cyclin D1, and c-myc (LIN2023Structure).


## References


[1. (Li2020TNFAIP8L2TIPE2) Wen Li, Yulan Li, Yetong Guan, Yingxin Du, Mingsheng Zhao, Xiaotong Chen, Faliang Zhu, Chun Guo, Yufeng Jia, Yuan Li, Xiaoyu Wang, Xiaoyan Wang, Yongyu Shi, Qun Wang, Yan Li, and Lining Zhang. Tnfaip8l2/tipe2 impairs autolysosome reformation via modulating the rac1-mtorc1 axis. Autophagy, 17(6):1410–1425, May 2020. URL: http://dx.doi.org/10.1080/15548627.2020.1761748, doi:10.1080/15548627.2020.1761748. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1080/15548627.2020.1761748)

[2. (Sullivan2017Evolutionary) Con Sullivan, Christopher R. Lage, Jeffrey A. Yoder, John H. Postlethwait, and Carol H. Kim. Evolutionary divergence of the vertebrate tnfaip8 gene family: applying the spotted gar orthology bridge to understand ohnolog loss in teleosts. PLOS ONE, 12(6):e0179517, June 2017. URL: http://dx.doi.org/10.1371/journal.pone.0179517, doi:10.1371/journal.pone.0179517. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0179517)

[3. (Zou2021Tumor) Ziqi Zou, Mengyao Li, Yunlian Zhou, Jiaying Li, Ting Pan, Lihua Lai, Qingqing Wang, Lining Zhang, Qun Wang, Yinjing Song, and Yuanyuan Zhang. Tumor necrosis factor-α-induced protein 8-like 2 negatively regulates innate immunity against rna virus by targeting rig-i in macrophages. Frontiers in Immunology, March 2021. URL: http://dx.doi.org/10.3389/fimmu.2021.642715, doi:10.3389/fimmu.2021.642715. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2021.642715)

[4. (LIN2023Structure) ZIPENG LIN, CHUXI TANG, LE KANG, GUANXI LAI, SHIWEN LIU, YIXIANG WU, HUIQUN TIAN, and SONG LIU. Structure, function, and mechanism of the tnfaip8 (tipe) family of proteins in cancer and inflammation. BIOCELL, 47(10):2217–2232, 2023. URL: http://dx.doi.org/10.32604/biocell.2023.030233, doi:10.32604/biocell.2023.030233. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.32604/biocell.2023.030233)

5. (Chen2023Human) Human pan-cancer analysis of the predictive biomarker for the tumor necrosis factor-alpha-induced protein 8-like 2 (TNFAIP8L2). This article has 0 citations.

[6. (Bordoloi2018TIPE) Devivasha Bordoloi, Kishore Banik, Bano Shabnam, Ganesan Padmavathi, Javadi Monisha, Frank Arfuso, Arunasalam Dharmarajan, Xinliang Mao, Lina Lim, Lingzhi Wang, Lu Fan, Kam Hui, Alan Kumar, Gautam Sethi, and Ajaikumar Kunnumakkara. Tipe family of proteins and its implications in different chronic diseases. International Journal of Molecular Sciences, 19(10):2974, September 2018. URL: http://dx.doi.org/10.3390/ijms19102974, doi:10.3390/ijms19102974. This article has 54 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms19102974)

[7. (Zhang2024Comprehensive) Xuezhong Zhang, Xuebin Zhang, Tonggang Liu, and Kaihui Sha. Comprehensive analysis of the prognostic and immunological signature of tnfaip8 family genes in human glioma. Scientific Reports, August 2024. URL: http://dx.doi.org/10.1038/s41598-024-68784-y, doi:10.1038/s41598-024-68784-y. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-024-68784-y)